Inmed Pharmaceuticals Inc (INM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,944 | -3,843 | -1,599 | -8,939 | -7,323 |
| Depreciation Amortization | 92 | 65 | 28 | 112 | 86 |
| Accounts receivable | -18 | -103 | -6 | 17 | 30 |
| Other Working Capital | -1,461 | 285 | 110 | 358 | 326 |
| Other Operating Activity | 547 | 423 | 96 | 1,076 | 906 |
| Operating Cash Flow | $-7,785 | $-3,173 | $-1,372 | $-7,375 | $-5,976 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 3,833 | 3,833 |
| PPE Investments | N/A | N/A | N/A | -42 | -43 |
| Investing Cash Flow | $N/A | $N/A | $N/A | $3,791 | $3,790 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 12,473 | 8,010 | N/A | N/A | N/A |
| Other Financing Activity | -1,535 | -1,117 | -65 | -31 | 0 |
| Financing Cash Flow | $10,938 | $6,893 | $-65 | $-31 | $N/A |
| Exchange Rate Effect | 495 | 495 | 128 | -416 | -682 |
| Beginning Cash Position | 5,806 | 5,806 | 5,806 | 9,837 | 9,837 |
| End Cash Position | 9,454 | 10,021 | 4,497 | 5,806 | 6,969 |
| Net Cash Flow | $3,648 | $4,215 | $-1,309 | $-4,031 | $-2,869 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,785 | -3,173 | -1,372 | -7,375 | -5,976 |
| Capital Expenditure | N/A | N/A | N/A | -43 | -44 |
| Free Cash Flow | -7,785 | -3,173 | -1,372 | -7,418 | -6,020 |